TrialNature communications2025

Apatinib plus ifosfamide and etoposide versus ifosfamide and etoposide in patients with advanced osteosarcomas (OAIE/PKUPH-sarcoma 11): a randomized phase II study.

Lu Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.